Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, R.
Right arrow Articles by Moss, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, R.
Right arrow Articles by Moss, S. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 7 796-801, Copyright © 1995 by American Diabetes Association


ARTICLES

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy

R Klein, BE Klein and SE Moss
Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison 53705-2397, USA.

The relationship between plasma C-peptide and the 6-year incidence and progression of diabetic retinopathy was examined in a population-based study in Wisconsin. Individuals with younger-onset (n = 548) and older-onset (n = 459) diabetes were included. C-peptide was measured by radioimmunoassay with Heding's M1230 antiserum. Retinopathy was determined from stereoscopic fundus photographs. Younger- and older-onset insulin-using individuals with undetectable or low plasma C-peptide (< 0.3 nmol/l) at baseline had the highest incidence and rates of progression of retinopathy, whereas older-onset individuals with C-peptides > 0.3 nmol/l had the lowest incidence and rates of progression of retinopathy. However, within each group (younger-onset using insulin, older-onset using insulin, and older-onset not using insulin), after we controlled for other characteristics associated with retinopathy, there was no relationship between higher levels of C-peptide at baseline and lower 6-year incidence or progression of retinopathy. These data suggest that glycemic control, and not C-peptide, is related to the incidence and progression of diabetic retinopathy.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. B. Soumerai, C. Mah, F. Zhang, A. Adams, M. Barton, V. Fajtova, and D. Ross-Degnan
Effects of Health Maintenance Organization Coverage of Self-monitoring Devices on Diabetes Self-care and Glycemic Control
Arch Intern Med, March 22, 2004; 164(6): 645 - 652.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. J. Tapp, J. E. Shaw, C. A. Harper, M. P. de Courten, B. Balkau, D. J. McCarty, H. R. Taylor, T. A. Welborn, and P. Z. Zimmet
The Prevalence of and Factors Associated With Diabetic Retinopathy in the Australian Population
Diabetes Care, June 1, 2003; 26(6): 1731 - 1737.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Pozzilli and U. Di Mario
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention
Diabetes Care, August 1, 2001; 24(8): 1460 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C. Giusti, R. Schiaffini, C. Brufani, A. Pantaleo, E. M. Vingolo, and P. Gargiulo
Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients
Br. J. Ophthalmol., June 1, 2000; 84(6): 591 - 595.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.